Literature DB >> 10573290

Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality.

E Di Paolo1, J P Vilardaga, H Petry, N Moguilevsky, A Bollen, P Robberecht, M Waelbroeck.   

Abstract

The secretin receptor is a member of a large family of G-protein-coupled receptors that recognize polypeptide hormone and/or neuropeptides. Charged, conserved residues might play a key role in their function, either by interacting with the ligand or by stabilizing the receptor structure. Of the four charged amino acids that are conserved in the whole secretin receptor family, D49 and R83 (in the N-terminal domain) were probably important for the secretin receptor structure: replacement of D49 by H or R and of R83 by D severely reduced both the maximal response to secretin and its potency. No functional secretin receptor could be detected after replacement of R83 by L. Mutation of D49 to E, A, or N had no effect or reduced 5-fold the potency of secretin. The highly conserved positive charges found at the extracellular ends of TM III (K194) and IV (R255) were important for the secretin receptor function, as K194 mutation to A or Q and R255 mutation to Q or D decreased the secretin's affinity 15- to 1000-fold, respectively. Six extracellular charged residues are conserved in closely related receptors but not in the whole family. K121 (TM I) and R277 (TM V) were not important for functional secretin receptor expression. D174 (TM II) was necessary to stabilize the active receptor structure: the D174N mutant receptors were unable to stimulate normally the adenylate cyclase in response to secretin, and functional D174A receptors could not be found. Mutation of R255, E259 (second extracellular loop), and E351 (third extracellular loop) to uncharged residues reduced only 10- to 100-fold the secretin potency without changing its efficacy: these residues either stabilized the active receptor conformation or formed hydrogen rather than ionic bonds with secretin. Mutation of K121 (TM I) to Q or L and of R277 (TM V) to E or Q did not affect the receptor functional properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573290     DOI: 10.1016/s0196-9781(99)00122-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

1.  Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.

Authors:  Yuko Fujiwara; Daniel A Osborne; Michelle D Walker; De-an Wang; Debra A Bautista; Karoly Liliom; James R Van Brocklyn; Abby L Parrill; Gabor Tigyi
Journal:  J Biol Chem       Date:  2006-11-18       Impact factor: 5.157

Review 2.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

Authors:  James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.

Authors:  P Vertongen; R M Solano; J Perret; I Langer; P Robberecht; M Waelbroeck
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 5.  Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor.

Authors:  Laurence J Miller; Maoqing Dong; Kaleeckal G Harikumar
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

Authors:  Jason Perret; Mélanie Van Craenenbroeck; Ingrid Langer; Pascale Vertongen; Françoise Gregoire; Patrick Robberecht; Magali Waelbroeck
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

7.  Structure of the human glucagon class B G-protein-coupled receptor.

Authors:  Fai Yiu Siu; Min He; Chris de Graaf; Gye Won Han; Dehua Yang; Zhiyun Zhang; Caihong Zhou; Qingping Xu; Daniel Wacker; Jeremiah S Joseph; Wei Liu; Jesper Lau; Vadim Cherezov; Vsevolod Katritch; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

8.  Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification.

Authors:  Abhishek Tripathi; Vikas Saini; Adriano Marchese; Brian F Volkman; Wei-Jen Tang; Matthias Majetschak
Journal:  Biochemistry       Date:  2013-06-07       Impact factor: 3.162

9.  Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function.

Authors:  James Barwell; Alex Conner; David R Poyner
Journal:  Biochim Biophys Acta       Date:  2011-06-16

10.  The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.

Authors:  Michael J Woolley; Harriet A Watkins; Bruck Taddese; Z Gamze Karakullukcu; James Barwell; Kevin J Smith; Debbie L Hay; David R Poyner; Christopher A Reynolds; Alex C Conner
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.